Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Iteos Therapeutics, Inc. (ITOS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 37,960,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 5,000 5,000
Total Buy Value $0 $0 $41,850 $41,850
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 350,000 1,417,615
Total Sell Value $0 $0 $5,692,673 $30,486,992
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 9
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 227
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gall Matthew Chief Financial Officer   •       –      –    2023-12-05 4 A $0.00 $0 D/D 41,000 60,429     -
   Detheux Michel Chief Executive Officer   •       –      –    2023-12-05 4 A $0.00 $0 D/D 30,000 58,903     -
   Mcgrath Yvonne Chief Scientific Officer   •       –      –    2023-12-05 4 A $0.00 $0 D/D 31,000 31,000     -
   Call Matthew Chief Operating Officer   •       –      –    2023-12-05 4 A $0.00 $0 D/D 44,000 137,898     -
   Gall Matthew Chief Financial Officer   •       –      –    2023-10-12 4 B $8.37 $41,850 D/D 5,000 19,429 2.74     -
   Davis Aaron I. See remarks   •       •      –    2023-08-23 4 S $14.19 $5,692,673 D/D (350,000) 1,804,058     -
   Call Matthew Chief Operating Officer   •       –      –    2023-03-28 4 OE $2.95 $118,667 D/D 40,226 93,898     -
   Hallal David Director   –       •      –    2022-06-09 4 S $19.51 $22,846 D/D (1,171) 0     -
   Hallal David Director   –       •      –    2022-06-09 4 OE $4.23 $4,953 D/D 1,171 1,171     -
   Hallal David Director   –       •      –    2022-06-08 4 S $19.86 $574,367 D/D (28,444) 0     -
   Hallal David Director   –       •      –    2022-06-08 4 OE $2.95 $105,087 D/D 28,444 10,577     -
   Davis Aaron I. Director   –       •      –    2022-05-11 4 S $17.53 $6,167,422 I/I (338,000) 2,154,058     -
   Davis Aaron I. Director   –       •      –    2022-05-10 4 S $24.77 $2,515,970 I/I (100,000) 2,492,058     -
   Davis Aaron I. Director   –       •      –    2022-05-09 4 S $22.91 $5,265,843 I/I (225,000) 2,592,058     -
   Davis Aaron I. Director   –       •      –    2022-05-02 4 S $26.91 $2,748,734 I/I (100,000) 2,817,058     -
   Davis Aaron I. Director   –       •      –    2022-04-29 4 S $27.01 $3,388,822 I/I (125,000) 2,917,058     -
   Davis Aaron I. Director   –       •      –    2022-04-28 4 S $27.40 $4,110,315 I/I (150,000) 3,042,058     -
   Detheux Michel Chief Executive Officer   •       –      –    2022-04-18 4 S $31.87 $366,530 D/D (11,500) 26,263     -
   Detheux Michel Chief Executive Officer   •       –      –    2022-04-18 4 OE $4.23 $48,645 D/D 11,500 37,763     -
   Davis Aaron I. Director   –       •      –    2022-03-23 4 B $32.85 $656,980 I/I 20,000 3,192,058 2.1     -
   Davis Aaron I. Director   –       •      –    2022-03-22 4 B $31.88 $968,509 I/I 30,000 3,172,058 2.1     -
   Detheux Michel Chief Executive Officer   •       –      –    2022-03-22 4 AS $33.44 $629,987 D/D (18,437) 26,263     -
   Lewis Joseph 10% Owner   –       –       •   2022-03-17 4 S $35.25 $20,275,835 D/D (575,201) 3,142,058     -
   Detheux Michel Chief Executive Officer   •       –      –    2022-03-11 4 A $0.00 $0 D/D 10,000 44,700     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2022-03-11 4 S $36.01 $126,035 D/D (3,500) 0     -
  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us